Account
Articles
23.05.2023
How has the COVID-19 pandemic impacted the use of ...

Digital health technology played a vital role during the COVID-19 pandemic as there was a rapid usag...

Read more
Case Studies
26.04.2023
Development of an EU go-to-market access plan

Our client is developing best-in-class antibodies to neutralise coronaviruses. Our client wanted to...

Read more
Insider Insights
22.02.2023
NICE announces the development of a new rapid revi...

New process to assess clinical and cost-effectiveness of COVID-19 treatments to get these medicines ...

Read more
News
15.12.2022
PMA Insights: Week 50

We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...

Read more
Insider Insights
04.05.2022
The European Health Data Space launch

The EHDS will integrate three main product markets for primary use of health data: electronic health...

Read more
Insider Insights
25.03.2022
UK-wide commitments for genomics initiatives

According to the Department of Health and Social Care (DHSC), the commitments will enable patients t...

Read more
Insider Insights
02.03.2022
Use of COVID-19 treatments granted early access 20

According to the National Agency for Drug Safety, there are currently four treatments available thro...

Read more
Insider Insights
21.02.2022
CNAM spending on reimbursed medicines

Reimbursed spending by the CNAM on out-patient care (including care from general practitioners [GPs]...

Read more
Articles
25.01.2022
PMA Perspectives Q1 2022

We hope you’ve had a wonderful start to the New Year and we’d love to welcome you to our fourth ...

Read more
Articles
17.01.2022
COVID-19 Two Year Review

As we enter 2022, we are approaching the two-year anniversary of the COVID-19 pandemic spreading acr...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.